SCHEMBL16995339

SCHEMBL16995339

O=CNc1ncc(C(=O)O)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.48
FFAR2 O15552 1/20 0.45
RAB9A P51151 9/20 0.41
NPC1 O15118 8/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPK13 O15264 3/20 0.41
MAPK12 P53778 3/20 0.41
MAPK11 Q15759 3/20 0.41
MAPK14 Q16539 3/20 0.41
SMN1; SMN2 Q16637 6/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
MAPT P10636 3/20 0.38
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37
CDK5 Q00535 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9481356 0.86 RAB9A (0.40) HCAR2FFAR2RAB9ANPC1CYP1A2
SCHEMBL5214094 0.84 FFAR2 (0.49) HCAR2FFAR2RAB9ANPC1CYP1A2
SCHEMBL14887666 0.84 FFAR2 (0.46) FFAR2RAB9ANPC1CYP1A2CYP3A4
SCHEMBL11165530 0.82 RAB9A (0.37) FFAR2RAB9ANPC1CYP1A2CYP3A4
SCHEMBL11165532 0.82 RAB9A (0.37) FFAR2RAB9ANPC1CYP1A2CYP3A4
SCHEMBL4256153 0.77 RAB9A (0.65) HCAR2FFAR2RAB9ANPC1CYP1A2
SCHEMBL22750823 0.77 HCAR2 (0.52) HCAR2FFAR2RAB9ANPC1CYP1A2
SCHEMBL9481429 0.76 MAPT (0.39) FFAR2RAB9ANPC1CYP1A2CYP3A4
SCHEMBL9481438 0.76 MAPT (0.39) FFAR2RAB9ANPC1CYP1A2CYP3A4
SCHEMBL186141 0.74 HCAR2 (0.53) HCAR2FFAR2RAB9ANPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576586-B1 C-28 AMIDES OF MODIFIED C-3 BETULINIC ACID DERIVATIVES AS HIV MATURATION INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2015-08-12 EP disclosed